Anthracyclines in haematology: preclinical studies, toxicity and delivery systems.

Abstract:

:The anthracyclines are widely used in the treatment of haematological and non-haematological malignancy and there is now more than 30 years' clinical experience with these agents but despite this, their mechanism of action is incompletely understood. The anthracyclines have been shown to intercalate with DNA and indirectly inhibit the activity of the enzyme topoisomerase II, resulting in DNA strand breaks. More recently, workers have focused on induction of apoptosis and have shown that daunorubicin stimulates production of the apoptotic mediator, ceramide and that the activity of doxorubicin can be blocked by inhibitors of CD95 (fas). One of the major problems with anthracycline therapy is the development of resistance which may be mediated by p-glycoprotein or by other mechanisms. Much recent research has concentrated on methods to modulate the drug-resistant phenotype and these include development of new analogues and use of specific reversal agents. The toxicity profile of the anthracyclines includes bone marrow suppression, severe local reaction following extravasation, radiation recall, alopecia, gastrointestinal and hepatic effects, development of secondary malignancies and significant cardiac toxicity. The risk factors for the development of anthracycline-related cardiac toxicity are well documented and several methods have been exploited in attempts at prevention. Finally, a number of drug delivery systems have been developed in order to improve therapeutic response and reduce toxicity to normal tissues, including the use of liposomal preparations.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Richardson DS,Johnson SA

doi

10.1016/s0268-960x(97)90020-5

subject

Has Abstract

pub_date

1997-12-01 00:00:00

pages

201-23

issue

4

eissn

0268-960X

issn

1532-1681

pii

S0268-960X(97)90020-5

journal_volume

11

pub_type

杂志文章,评审
  • Management of challenging myelofibrosis after JAK inhibitor failure and/or progression.

    abstract::The myeloproliferative neoplasms (MPNs) encompass a heterogenous set of diseases that have variable survival, but in the setting of treatment refractory and progressive disease, prognosis has been characteristically poor. JAK inhibition with ruxolitinib or fedratinib therapy has become the first line treatment for sym...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100716

    authors: Scherber RM,Mesa RA

    更新日期:2020-07-01 00:00:00

  • Human retroviruses.

    abstract::After many unsuccessful years of searching, the first pathogenic human retrovirus, the human T-cell leukaemia lymphoma virus (HTLV-I), was reported as recently as 1980 and since that time has been causally linked to the adult T-cell leukaemia lymphoma syndrome. A second HTLV (HTLV-II) isolated shortly afterwards is le...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90010-0

    authors: Thomson BJ,Dalgleish AG

    更新日期:1988-12-01 00:00:00

  • Hemophilia A in the third millennium.

    abstract::Hemophilia A is an X-linked hereditary bleeding disorder due to the deficiency of coagulation factor VIII (FVIII). According to the degree of FVIII deficiency, mild, moderate or severe forms are recognized. Although patients with mild hemophilia A usually bleed excessively only after trauma or surgery, those with seve...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.06.002

    authors: Franchini M,Mannucci PM

    更新日期:2013-07-01 00:00:00

  • Myelodysplasic syndromes: a comprehensive review.

    abstract::Myelodysplastic syndromes (MDS) are a set of oligoclonal disorders of hematopoietic stem cells characterized by ineffective hematopoiesis that manifest clinically as anemia, neutropenia, and/or thrombocytopenia of variable severity. The result often is transfusion-dependent anemia, an increased risk of infection or he...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.01.004

    authors: Catenacci DV,Schiller GJ

    更新日期:2005-11-01 00:00:00

  • A logical approach to the investigation of red cell enzymopathies.

    abstract::This relatively rare group of disorders may cause quite marked morbidity and occasionally be life-threatening. As their inheritance is largely known accurate information in one family member has obvious benefits to other family members as well as the patient. The identification of the defect is dependent on an accurat...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(90)90042-q

    authors: Lestas AN,Bellingham AJ

    更新日期:1990-09-01 00:00:00

  • The role of unrelated bone-marrow transplantation in childhood acute leukaemia.

    abstract::Early reports would suggest that closely matched UD BMT is an adequate substitute for MSD BMT in children with relapsed ALL. Protagonists of BMT might suggest that UD BMT be used in the absence of a MSD in all cases of BM relapse of ALL. However, recent improvements in chemoradiotherapy schedules have reduced the bene...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(96)90006-5

    authors: Veys P

    更新日期:1996-12-01 00:00:00

  • Hemophagocytic syndromes.

    abstract::Hemophagocytic syndromes (hemophagocytic lymphohistiocytosis, HLH) represent a severe hyperinflammatory condition with the cardinal symptoms prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages. Biochemical markers include elevated ferritin and triglyce...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2007.05.001

    authors: Janka GE

    更新日期:2007-09-01 00:00:00

  • Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.

    abstract::Stimulation with the vasopressin analogue desmopressin (DDAVP) of extrarenal arginine vasopressin (AVP) V2-receptors in endothelial cells and possible in platelets increases the circulating levels of coagulation factor VIII (FVIII), von Willebrand factor (VWF) and tissue plasminogen activator (t-PA). The purpose of th...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.03.001

    authors: Svensson PJ,Bergqvist PB,Juul KV,Berntorp E

    更新日期:2014-05-01 00:00:00

  • Congenital platelet disorders.

    abstract::Congenital platelet disorders include thrombocytopathies and thrombocytopenias, which often occur in association. Thrombocytopathies constitute a model for exploring platelet physiology at the molecular level: adhesion, activation, release phenomena, aggregation. Further advances in understanding thrombocytopenias now...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90004-5

    authors: Bellucci S,Caen JP

    更新日期:1988-03-01 00:00:00

  • MDS: Refining existing therapy through improved biologic insights.

    abstract::Advances in therapy can essentially be measured using two parameters; introduction of a new agent which benefits an increased number of patients over prevailing treatments or more selective use of an existing drug by matching it to the biologic characteristics associated with response. In reviewing the therapeutic lan...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2011.11.001

    authors: Schecter J,Galili N,Raza A

    更新日期:2012-03-01 00:00:00

  • Evaluation of mild bleeding disorders and easy bruising.

    abstract::The diagnostic approach to easy bruising or a suspected mild bleeding disorder includes a careful history and physical examination as well as laboratory investigations. The history should determine whether or not a bleeding disorder exists and help elucidate possible causes. The physical examination should evaluate ev...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(05)80014-1

    authors: Sham RL,Francis CW

    更新日期:1994-06-01 00:00:00

  • The place of radiotherapy in stage I and IIA Hodgkin's disease (or radiotherapy revisited).

    abstract::For the majority of patients presenting with early Hodgkin's disease, the chance of death due to their disease is related to prognostic factors, e.g. age, systemic symptoms, ESR bulk, number of sites of disease, histology, haemoglobin, lymphocyte count etc. More than 50% of those with Stage I and IIA disease fall into...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(91)90011-z

    authors: Maher EJ

    更新日期:1991-12-01 00:00:00

  • The regulation of megakaryocytopoiesis.

    abstract::The process of megakaryocytopoiesis begins with the commitment of a pluripotent hematopoietic stem cell to a differentiation pathway that culminates in the release of mature platelets into the circulation. A variety of megakaryocyte precursor cells have been identified after stem cell commitment has occurred and these...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(95)90034-9

    authors: Ellis MH,Avraham H,Groopman JE

    更新日期:1995-03-01 00:00:00

  • Management of refractory idiopathic thrombocytopenia.

    abstract::In refractory thrombocytopenia one should first evaluate whether the therapeutic approach has more risks to the patient than no treatment at all. The patient may remain relatively asymptomatic and the only incommoding circumstances be cosmetic. Coincidental medical problems such as hypertension and peptic ulceration a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90020-3

    authors: Firkin BG,Hunt HA,Jane SM

    更新日期:1988-09-01 00:00:00

  • Platelet-neutrophil interactions: their significance.

    abstract::In the vicinity of an acute inflammatory response both cellular and non-cellular elements may interact to modify the overall response. Evidence suggests that leukocytes may play an active role in the modulation of platelet function and vice-versa. This interaction may be abnormal in certain pathological states. Neutro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(92)90010-n

    authors: Faint RW

    更新日期:1992-06-01 00:00:00

  • Treatment of musculo-skeletal pain in haemophilia.

    abstract::Musculo-skeletal pain treatment is inadequate in many haemophilic patients. Analgesics are used only by 36% of adult patients. FVIII/FIX intravenous infusion is mainly used to lessen pain, followed in frequency by usage of NSAIDS (primarily COX-2 inhibitors). In about 30% of patients, pain continues after infusion of ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.09.004

    authors: Rodriguez-Merchan EC

    更新日期:2018-03-01 00:00:00

  • Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry.

    abstract::The clinical relevance of flow cytometry (FC)-based bone marrow involvement (BMI) in B cell non-Hodgkin lymphoma (B-NHL) is not well established. We conducted a systematic review of MEDLINE regarding the use of FC to establish BMI in B-NHL to determine the prevalence of BMI by FC, to understand the interrelation betwe...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100778

    authors: Sorigue M,Cañamero E,Miljkovic MD

    更新日期:2020-11-08 00:00:00

  • Screening and genetic diagnosis of haemoglobin disorders.

    abstract::The inherited haemoglobinopathies are large group of disorders that include the thalassaemias and sickle cell disease. Carrier detection methods must be able to detect alpha-, beta- and deltabeta-thalassaemias, HPFH disorders and haemoglobin variants. Carrier diagnosis involves the accurate measurement of MCH, MCV, Hb...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(02)00061-9

    authors: Old JM

    更新日期:2003-03-01 00:00:00

  • Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management.

    abstract::A working diagnosis of essential thrombocythemia (ET) is made in the presence of nonreactive thrombocytosis and after the exclusion of another chronic myeloid disorder that may mimic ET in its presentation. Clinically, ET is characterized by vasomotor symptoms, thrombohemorrhagic complications, recurrent fetal loss, a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0158

    authors: Tefferi A,Murphy S

    更新日期:2001-09-01 00:00:00

  • Intensive chemotherapy in myelodysplastic syndromes.

    abstract::Patients with myelodysplastic syndrome (MDS) who have more than 10% blasts in their bone marrow have a very short survival. Treatment has not improved for these patients for the past 10 years and supportive care alone is still the gold standard. Intensive chemotherapy for poor prognosis MDS has been little tried, but ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(92)90017-k

    authors: Hamblin TJ

    更新日期:1992-12-01 00:00:00

  • Venous thromboembolism incidence in hematologic malignancies.

    abstract::Venous thromboembolism (VTE) remains a major cause of morbidity and mortality in patients with cancer. Although some very well validated scores delineate the risk of VTE by cancer subtype and other risk factors, hematologic malignancies are underrepresented in these models. This subgroup represents a unique entity tha...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2018.06.002

    authors: Kekre N,Connors JM

    更新日期:2019-01-01 00:00:00

  • Idiopathic myelofibrosis: historical review, diagnosis and management.

    abstract::Idiopathic myelofibrosis is reviewed from several aspects. The historical development of knowledge about this disorder is discussed, from early descriptions of extramedullary hematopoiesis associated with numerous etiologies, a debate over pathogenetic mechanisms, followed by newer evidence which placed this disorder ...

    journal_title:Blood reviews

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/0268-960x(91)90041-a

    authors: Weinstein IM

    更新日期:1991-06-01 00:00:00

  • Thrombopoietic agents.

    abstract::Thrombopoietin (TPO) is the key cytokine involved in thrombopoiesis, and is the endogenous ligand for the thrombopoietin receptor that is expressed on the surface of platelets, megakaryocytes, and megakaryocytic precursors. First-generation thrombopoietic agents were recombinant forms of human TPO, and their developme...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2010.04.002

    authors: Stasi R,Bosworth J,Rhodes E,Shannon MS,Willis F,Gordon-Smith EC

    更新日期:2010-07-01 00:00:00

  • The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy.

    abstract::The finding that T cell immune responses could be divided into those promoting cell mediated immunity (Th1) and humoral responses (Th2) has had a profound effect on the understanding of immune response generation over the last 15 years. With ever increasing knowledge of the immune system, the model has come under crit...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2000.0136

    authors: Lappin MB,Campbell JD

    更新日期:2000-12-01 00:00:00

  • Stem cell factor: laboratory and clinical aspects.

    abstract::Stem cell factor is an essential haemopoietic progenitor cell growth factor with proliferative and anti-apoptotic functions. Molecular biologists have now dissected some of the various pathways through which this cytokine signals to the nucleus. At the same time, new molecules have become available which can inhibit S...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0167

    authors: Smith MA,Court EL,Smith JG

    更新日期:2001-12-01 00:00:00

  • Resuscitation and transfusion principles for traumatic hemorrhagic shock.

    abstract::The transfusion approach to massive hemorrhage has continually evolved since it began in the early 1900s. It started with fresh whole blood and currently consists of virtually exclusive use of component and crystalloid therapy. Recent US military experience has reinvigorated the debate on what the most optimal transfu...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2009.07.003

    authors: Spinella PC,Holcomb JB

    更新日期:2009-11-01 00:00:00

  • Mobilizing the older patient with myeloma.

    abstract::Although hematopoietic progenitor/stem cells (HPC) have been used for autologous transplants for approximately 25 years, it is only recently that we have begun to finally understand the factors which play important roles in causing these cells to leave their marrow niches and circulate in the blood. Still less is unde...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.06.001

    authors: Cottler-Fox M,Lapidot T

    更新日期:2006-01-01 00:00:00

  • RhD haemolytic disease of the fetus and the newborn.

    abstract::When an RhD negative mother is exposed to the RhD positive red cells (usually as transplacental haemorrhage), she develops allo-anti-D which crosses the placenta and then results in the destruction of fetal red cells. Clinical manifestations of RhD haemolytic disease (HDN) range from asymptomatic mild anaemia to hydro...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.1999.0123

    authors: Urbaniak SJ,Greiss MA

    更新日期:2000-03-01 00:00:00

  • Targeting platelet receptor function in thrombus formation: the risk of bleeding.

    abstract::In this review, we presume that the process of thrombus formation, as assessed in whole blood flow studies and in experimental (murine) thrombosis studies, reflects the platelet responses in human haemostasis and thrombosis. Following this concept, we give an up-to-date overview of the main platelet receptors and sign...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.12.001

    authors: Swieringa F,Kuijpers MJ,Heemskerk JW,van der Meijden PE

    更新日期:2014-01-01 00:00:00

  • Cerebral venous thrombosis-a primer for the haematologist.

    abstract::Cerebral venous thrombosis (CVT) is a condition that can affect all age groups and can often be difficult to diagnose and treat. The difficulties in diagnosis are mainly due to the non-specific presenting features of CVT, which can range from isolated headache and visual or auditory problems, to serious symptoms such ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2014.09.006

    authors: Thorell SE,Parry-Jones AR,Punter M,Hurford R,Thachil J

    更新日期:2015-01-01 00:00:00